Log In
Print
BCIQ
Print
Print this Print this
 

ETC-1002

  Manage Alerts
Collapse Summary General Information
Company Esperion Therapeutics Inc.
DescriptionAMP-activated protein kinase (AMPK) activator and ATP citrate lyase (ACL) inhibitor
Molecular Target AMP-activated protein kinase (AMPK)
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today